Dr. Nino Mihatov, MD

Dr. Mihatov practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Mihatov's NPI, 1063859312, was assigned on May 28, 2013. Dr. Mihatov graduated from Duke University School Of Medicine in 2013. Dr. Mihatov's New York license number on file is 304144.

Dr. Mihatov's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Mihatov's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. Dr. Mihatov is also affiliated with Tisch Hospital. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Mihatov to 2 more clinical labs, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mihatov practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Mihatov's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Mihatov is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Mihatov's licenses on file in 2 states: New York and Massachusetts.

Dmand AI lists angioplasty, cardiac catheterization and circulation problems among the conditions Dr. Mihatov treats.

CMS data shows 949 Medicare services from Dr. Mihatov across 17 procedure codes in 2024, for 198 Medicare patients. Medicare paid $100,137 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 198 Medicare patients who saw Dr. Mihatov in 2024. The largest group is 75 to 84, with 79 patients. 75% of them have heart failure, and 75% have high blood pressure. 48% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mihatov's median patient age at 77, with 57% women.

In 2024, Dr. Mihatov wrote 594 Medicare Part D claims for 127 patients. 80% of them were for generic drugs. CMS names the drug for 473 of them, across 18 drugs with 11 or more claims each, at $130,488 in total drug cost. In 2023, CMS named 310 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Mihatov for performance year 2024, reported as part of a group. Dr. Mihatov accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mihatov as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 25 papers to Dr. Mihatov, published from 2012 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Percutaneous Coronary Intervention, Drug Therapy, Combination and Platelet Aggregation Inhibitors. Dr. Mihatov has published most often in Cardiol Rev. Dr. Mihatov's most frequent co-authors are Robert Wayne Yeh, MD, Ajay J. Kirtane, MD and Eric Alexander Secemsky, MD, MS.

CMS Open Payments shows 354 general payments to Dr. Mihatov from 28 drug and device companies from 2016 to 2025. Grants make up the largest share, 39% of the total. Medtronic, Inc. paid the most, $25,468.

Dr. Mihatov graduated from Duke University School Of Medicine in 2013. Dr. Mihatov is a member of ACC and Society for Cardiovascular Angiography & Interventions (SCAI).